Personalization of caffeine therapy for apnea of prematurity : a potential role for sensor technologies?
Kolukisa Birgec, Burcu and Toprak, Beyza and Mullen, Alexander Balfour (2026) Personalization of caffeine therapy for apnea of prematurity : a potential role for sensor technologies? Sensors, 26 (12). 3962. ISSN 1424-8220 (https://doi.org/10.3390/s26123962)
Preview |
Text.
Filename: Birgec-etal-Sensors-2026-Personalization-of-caffeine-therapy-for-apnea-of-prematurity.pdf
Final Published Version License:
Download (924kB)| Preview |
Abstract
Apnea of prematurity (AOP) remains a critical challenge in neonatal care, with caffeine citrate serving as the cornerstone of pharmacological intervention. However, the current standardized dosing schedule fails to account for significant inter-individual variability in caffeine pharmacokinetics and clinical response. This narrative review explores the transformative potential of integrating wearable sensor technologies and multi-modal data analytics into a closed-loop framework for personalized caffeine therapy. Based on a synthesis of current monitoring literature, we propose a theoretical, comprehensive monitoring system utilizing the area under the respiratory curve (rAUC) as a continuous proxy metric, alongside waveform amplitude analysis aligned with pediatric polysomnography standards. By incorporating emerging metrics such as respiratory rate variability (RRV) and hypoxic burden, the framework enables the objective quantification of respiratory stability. Furthermore, the integration of established neonatal intensive care unit (NICU) parameters for bradycardia and oxygen saturation detection provides a critical cross-validation layer to minimize artifact-induced false alarms. This conceptual model bridges the gap between advanced signal processing and clinical oversight, offering a scalable pathway toward precision dosing. By shifting from reactive to predictive neonatology, sensor-driven optimization can enhance therapeutic efficacy, reduce alarm fatigue, and ultimately improve developmental outcomes for preterm infants.
ORCID iDs
Kolukisa Birgec, Burcu, Toprak, Beyza and Mullen, Alexander Balfour
ORCID: https://orcid.org/0000-0001-7475-5543;
-
-
Item type: Article ID code: 96595 Dates: DateEvent22 June 2026Published20 June 2026AcceptedSubjects: Medicine > Pharmacy and materia medica Department: Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences
Strategic Research Themes > Health and WellbeingDepositing user: Pure Administrator Date deposited: 22 Jun 2026 14:08 Last modified: 14 Sep 2026 06:37 URI: https://strathprints.strath.ac.uk/id/eprint/96595
Tools
Tools






